proteomics; accessible proteins; cancer biomarkers; glycoproteins,
Abstract :
[en] The identification of specific biomarkers obtained directly from human pathological lesions remains a major challenge, because the amount of tissue available is often very limited. We have developed a novel, comprehensive, and efficient method permitting the identification and absolute quantification of potentially accessible proteins in such precious samples. This protein subclass comprises cell membrane associated and extracellular proteins, which are reachable by systemically deliverable substances and hence especially suitable for diagnosis and targeted therapy applications. To isolate such proteins, we exploited the ability of chemically modified biotin to label ex vivo accessible proteins and the fact that most of these proteins are glycosylated. This approach consists of three successive steps involving first the linkage of potentially accessible proteins to biotin molecules followed by their purification. The remaining proteins are then subjected to glycopeptide isolation. Finally, the analysis of the nonglycosylated peptides and their involvement in an in silico method increased the confident identification of glycoproteins. The value of the technique was demonstrated on human breast cancer tissue samples originating from 5 individuals. Altogether, the method delivered quantitative data on more than 400 potentially accessible proteins (per sample and replicate). In comparison to biotinylation or glycoprotein analysis alone, the sequential method significantly increased the number (≥30% and ≥50% respectively) of potentially therapeutically and diagnostically valuable proteins. The sequential method led to the identification of 93 differentially modulated proteins, among which several were not reported to be associated with the breast cancer. One of these novel potential biomarkers was CD276, a cell membrane-associated glycoprotein. The immunohistochemistry analysis showed that CD276 is significantly differentially expressed in a series of breast cancer lesions. Due to the fact that our technology is applicable to any type of tissue biopsy, it bears the ability to accelerate the discovery of new relevant biomarkers in a broad spectrum of pathologies.
Research Center/Unit :
Giga-Cancer - ULiège
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Turtoi, Andrei ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Labo de recherche sur les métastases
Dumont, Bruno ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Labo de recherche sur les métastases
Greffe, Yannick; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Labo de recherche sur les métastases
Blomme, Arnaud ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > GIGA-R : Labo de recherche sur les métastases
Mazzucchelli, Gabriel ; Université de Liège - ULiège > Center for Analytical Research and Technology (CART)
Delvenne, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
LIFRANGE, Eric ; Centre Hospitalier Universitaire de Liège - CHU > Sénologie
De Pauw, Edwin ; Université de Liège - ULiège > Département de chimie (sciences) > GIGA-R : Laboratoire de spectrométrie de masse (L.S.M.)
Castronovo, Vincenzo ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie générale et cellulaire
Language :
English
Title :
Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues
Publication date :
01 July 2011
Journal title :
Journal of Proteome Research
ISSN :
1535-3893
eISSN :
1535-3907
Publisher :
American Chemical Society, Washington, United States - District of Columbia
Volume :
10
Issue :
7
Pages :
3160-82
Peer reviewed :
Peer Reviewed verified by ORBi
European Projects :
FP7 - 201342 - ADAMANT - ANTIBODY DERIVATIVES AS MOLECULAR AGENTS FOR NEOPLASTIC TARGETING
Funders :
ULg - University of Liège CE - Commission Européenne Télévie CAC - Centre anticancéreux près l'Université de Liège asbl
Funding text :
This work was supported by a grant from the Research
Concerted Action (IDEA project) of the University of Li ege
(ULG), Belgium, from the CEE (FP7 network: ADAMANTAntibody
Derivatives As Molecular Agents for Neoplastic Targeting
(HEALTH-F2-2007-201342)), from the National Fund
for Scientific Research (NFSR, Belgium) and TELEVIE as well as
from the Centre Anti-Cancereux of the ULG. The authors
acknowledge the GIGA-Proteomics Platform of the ULG and
Pascale Heneaux (LRM) for experimental support.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Cancer diagnostics: discovery and clinical applications. Clin. Chem. 2002, 48 (whole issue), 1145-1375.
Recent advances in cancer biomarkers. Clin. Biochem. 2004, 37 (whole issue), 503-647.
Proteomics and biomarkers. J. Proteome Res. 2005, 4 (whole issue), 1053-1456.
Celis, J. E.; Gromov, P.; Cabezón, T.; Moreira, J. M.; Ambartsumian, N.; Sandelin, K.; Rank, F.; Gromova, I. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery Mol. Cell. Proteomics 2004, 3, 327-344 (Pubitemid 38702087)
Castronovo, V.; Kischel, P.; Guillonneau, F.; de Leval, L.; Deféchereux, T.; De Pauw, E.; Neri, D.; Waltregny, D. Identification of specific reachable molecular targets in human breast cancer using a versatile ex vivo proteomic method Proteomics 2007, 7, 1188-1196 (Pubitemid 46716046)
Wollscheid, B.; Bausch-Fluck, D.; Henderson, C.; O'Brien, R.; Bibel, M.; Schiess, R.; Aebersold, R.; Watts, J. D. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins Nat. Biotechnol. 2009, 27 (4) 378-386
Naeem, A.; Saleemuddin, M.; Khan, R. H. Glycoprotein targeting and other applications of lectins in biotechnology Curr. Protein Pept. Sci. 2007, 8 (3) 261-271 (Pubitemid 46979728)
Zhang, H.; Li, X. J.; Martin, D. B.; Aebersold, R. Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry Nat. Biotechnol. 2003, 21 (6) 660-666 (Pubitemid 36638093)
Zhang, H. Glycoproteomics using chemical immobilization Curr. Protoc. Protein Sci. 2007, 24 unit 24.3
Sun, B.; Ranish, J. A.; Utleg, A. G.; White, J. T.; Yan, X.; Lin, B.; Hood, L. Shotgun glycopeptide capture approach coupled with mass spectrometry for comprehensive glycoproteomics Mol. Cell. Proteomics 2007, 6, 141-149 (Pubitemid 46152699)
Chen, R.; Jiang, X.; Sun, D.; Han, G.; Wang, F.; Ye, M.; Wang, L.; Zou, H. Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry J. Proteome Res. 2009, 8, 651-661
Sprung, R. W., Jr.; Brock, J. W.; Tanksley, J. P.; Li, M.; Washington, M. K.; Slebos, R. J.; Liebler, D. C. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis Mol. Cell. Proteomics 2009, 8 (8) 1988-1998
Roth, T. J.; Sheinin, Y.; Lohse, C. M.; Kuntz, S. M.; Frigola, X.; Inman, B. A.; Krambeck, A. E.; McKenney, M. E.; Karnes, R. J.; Blute, M. L.; Cheville, J. C.; Sebo, T. J.; Kwon, E. D. B7-H3 ligand expression by prostate cancer: a novel marker of prognosis and potential target for therapy Cancer Res. 2007, 67, 7893-7900 (Pubitemid 47281385)
Crispen, P. L.; Sheinin, Y.; Roth, T. J.; Lohse, C. M.; Kuntz, S. M.; Frigola, X.; Thompson, R. H.; Boorjian, S. A.; Dong, H.; Leibovich, B. C.; Blute, M. L.; Kwon, E. D. Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma Clin. Cancer Res. 2008, 14 (16) 5150-5157
Castriconi, R.; Dondero, A.; Augugliaro, R.; Cantoni, C.; Carnemolla, B.; Sementa, A. R.; Negri, F.; Conte, R.; Corrias, M. V.; Moretta, L.; Moretta, A.; Bottino, C. Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 12640-12645 (Pubitemid 39122076)
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.